Peter Harvey
InvestorP2C Chief Financial Officer; NBDF Chief Business Officer at Pathway to Cures
About
Harvey serves as CFO of P2C and Chief Business Officer of NBDF, overseeing finance, accounting, and business development. He holds a B.A. in Biology from Augustana College and an MBA from the University of Chicago Booth School of Business.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Peter Harvey?
- Harvey serves as CFO of P2C and Chief Business Officer of NBDF, overseeing finance, accounting, and business development. He holds a B.A. in Biology from Augustana College and an MBA from the University of Chicago Booth School of Business.
- Where does Peter Harvey work?
- Peter Harvey is P2C Chief Financial Officer; NBDF Chief Business Officer at Pathway to Cures.